Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of Small Noncoding RNAs in Urinary Exosomes Classifies Prostate Cancer into Indolent and Aggressive Disease

19 Mar 2020

Abstract excerpt

PURPOSE: This is the first report of the development and performance of a platform that interrogates small noncoding RNAs (sncRNA) isolated from urinary exosomes. The Sentinel™ PCa Test classifies patients with prostate cancer from subjects with no evidence of prostate cancer, the miR Sentinel CS Test stratifies patients with prostate cancer between those with low risk prostate cancer (Grade Group 1) from those...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Extracellular vesicles in disease
Share to Prostate Cancer Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32191585
DOI: 10.1097/ju.0000000000001020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of Small Noncoding RNAs in Urinary Exosomes Classifies Prostate Cancer into Indolent and Aggressive DiseasePMID 32191585Read ↗

A sensitive and specific non-invasive urine biomarker panel for prostate cancer detectionSemantic proximity Read ↗

A five‐microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell‐free urineSemantic proximity Read ↗

A Urine-Based Exosomal Gene Expression Test Stratifies Risk of High-Grade Prostate Cancer in Men with Prior Negative Prostate Biopsy Undergoing Repeat BiopsySemantic proximity Read ↗

Development and Validation of MyProstateScore 2.0 to Detect Clinically Significant Prostate CancerSemantic proximity Read ↗

Integration of genomic classification and clinical characteristics predicts survival in metastatic prostate cancerSemantic proximity Read ↗

Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patientsSemantic proximity Read ↗

exRNA Signatures in Extracellular Vesicles and their Tumor-Lineage from Prostate CancerSemantic proximity Read ↗

Urinary extracellular vesicles miRNA—A new era of prostate cancer biomarkersSemantic proximity Read ↗

Noncoding RNAs in prostate cancer: the long and the short of it.Semantic proximity Read ↗

Machine learning–derived exosome-related biomarkers for prostate cancer diagnosis and AKR1B1-centered functional characterizationSemantic proximity Read ↗

Unveiling potential: urinary exosomal mRNAs as non-invasive biomarkers for early prostate cancer diagnosisSemantic proximity Read ↗

Prostate Cancer Specific Exosomal miRNAs in Saliva: a Way to a New and Dependable Screening MethodSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.